Half-year report · Q2
3747.TEDINET S100VRG8
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥863m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥940m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥62m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥85m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥160m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥27m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥38m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥32m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥40m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥49m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥17m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥411m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥413m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥819m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥819m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥994m | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥106m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥124m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥73m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.53 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.63 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.82 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥162m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥125m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥21m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥682m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥224m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥55m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥24m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥178m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥30,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥151m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥131m |
| jpcrp040300-q2r_E05424-000Business Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥5m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥751m |
| jpcrp040300-q2r_E05424-000Financial Solutionreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥240m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥59m |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| jpcrp040300-q2r_E05424-000Health Carereportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥22m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥940m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥30,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥213m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-10-01 | |
| Current period end date | FilingDateInstant | 2025-03-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2025-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Comparative period end date | FilingDateInstant | 2024-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(スタンダード市場) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)西本 一也 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都新宿区 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)株式会社ジャパンインベストメントアドバイザー | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都千代田区霞が関3-2-1 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)尾﨑 孝博 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)神奈川県横浜市保土ヶ谷区 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)モルガン・スタンレーMUFG証券株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町1-9-7 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)西本 かな | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都新宿区 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)日本証券金融株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋茅場町1-2-10 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)インタートレード従業員持株会理事長 原 英統 | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都中央区新川1-17-21 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)NOMURA INTERNATIONAL PLC A/C JAPAN FLOW (常任代理人 野村證券株式会社) | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋1-13-1 | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内1-4-5決済事業部 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)山口 文明 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京都杉並区 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |